<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CALCIUM LACTATE</span><br/>(lak'tate)<br/><span class="topboxtradename">Cal-Lac, </span><span class="topboxtradename">Calcimax, </span><span class="topboxtradename">Calcium Unison, </span><span class="topboxtradename">Ridactate<br/></span><b>Classifications:</b> <span class="classification">fluid and electrolytic balance agent</span>; <span class="classification">replacement solution</span><br/><b>Prototype: </b>Calcium gluconate<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>325 mg, 650 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Oral calcium preparation reportedly well tolerated. Calcium is an essential element for regulating the excitation threshold
         of nerves and muscles, for blood clotting mechanisms, cardiac function, maintenance of renal function, for body skeleton and
         teeth. Also plays a role in regulating storage and release of neurotransmitters and hormones, and in maintaining structural
         and functional integrity of cell membranes and capillaries. It increases cardiac muscle tone and force of systolic contractions
         (positive inotropic effect).
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Rapidly and effectively restores serum calcium levels in mild hypocalcemia of various origins and effective for calcium maintenance
         therapy.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Mild hypocalcemia and maintenance calcium therapy.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Ventricular fibrillation, metastatic bone disease, injection into myocardium; administration by SC or IM routes; renal calculi,
         hypercalcemia, predisposition to hypercalcemia (hyperparathyroidism, certain malignancies); pregnancy (category B).
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Digitalized patients, renal or cardiac insufficiency, sarcoidosis, history of lithiasis, immobilized patients; lactation.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td>
<p>
<b>All doses are in terms of <i>elemental calcium:</i> 1 g calcium lactate = 130 mg (6.5 mEq, 13%) elemental calcium</b>
</p><span class="indicationtitle">Supplement for Mild Hypocalcemia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 325 mgÂ–1.3 g t.i.d. with meals<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 500 mg/kg/d in divided doses<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Tablets or powder can be dissolved in hot water (if patient unable to swallow whole), then add cool water to make palatable.</li>
<li>Calcium lactate may be administered with lactose (amount prescribed) to increase solubility.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">GI:</span>
<span class="speceff-common">Constipation</span> or laxative effect, acid rebound, nausea, eructation, <span class="speceff-common">flatulence,</span> vomiting, fecal concretions. <span class="typehead">Metabolic:</span> Hypercalcemia with alkalosis, metastatic calcinosis, hypercalciuria, hypomagnesemia, hypophosphatemia (when phosphate intake
      is low). <span class="typehead">CNS:</span> Mood and mental changes, <span class="typehead">Urogenital:</span> Polyuria, renal calculi. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> May enhance inotropic and toxic effects of <b>digoxin;</b>
<b>magnesium</b> may compete for GI absorption; decreases absorption of <span class="classification">tetracyclines</span>, <span class="classification">quinolones</span><b> (ciprofloxacin)</b>. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Approximately <small>1/3</small> of dose absorbed from small intestine. <span class="typehead">Distribution:</span> Crosses placenta. <span class="typehead">Elimination:</span> Primarily excreted in feces; small amounts excreted in urine, pancreatic juice, saliva, and breast milk. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for hypercalcemia (see Signs &amp; Symptoms, Appendix F).</li>
<li>Lab tests: Check serum calcium levels periodically. Hypercalcemia can occur during prolonged administration particularly if
            patient is also taking vitamin D.
         </li>
<li>Monitor increases in serum calcium in digitalized patients as this increases risk of digitalis toxicity.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Confer with physician regarding need for vitamin D supplementation.</li>
<li>Calcium absorption can be inhibited by zinc-rich foods such as nuts, sprouts, legumes, and soy products.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>